Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly Plans to Spend $27 Billion on New U.S. Plants
Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company ...
BioPharma Dive3h
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly to build 4 more manufacturing sites in US
Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...
Eli Lilly CEO on $27 billion investment in U.S. manufacturing expansion
CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S.
FiercePharma4h
With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing
Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...
Lilly plans to build four new pharmaceutical manufacturing sites in the U.S.
Eli Lilly (LLY) and Company announced at plans to bolster its domestic medicine production across therapeutic areas by building four new ...
Eli Lilly Plans to Spend $27 Billion on Four New U.S. Plants
U.S. Secretary of Commerce Howard Lutnick said Lilly was doing "exactly what the President was hoping would happen." ...
Eli Lilly Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since October 2023 — Data Talk
Eli Lilly Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since October 2023 — Data Talk Eli Lilly and Company (LLY) is currently at $915.07, up $13.27 or 1.47% --Would be ...